Type of security: Stock
Sector: Health Care
Industry: Hospital/Nursing Management
The data is delayed by 15 minutes.
Description: DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease. It operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals. The company offers outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; ESRD clinical research programs; physician services; and direct primary care services. As of March 31, 2014, it operated 2,173 outpatient dialysis centers, including 2,098 centers located in the United States; and 75 centers located in 10 countries outside the United
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||-232.26%||EPS Growth - Q/Q||-192.85%|
|EPS Growth - Y/Y||16.12%||Sales Growth - 4 Quarters||3.64%||Sales Growth - Q/Q||-1.2%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||2.34%||ROE||7.37%||ROI||3.12%|
|Current Ratio||1.61||Quick Ratio||1.55||Long Term Debt/Equity||5.17||Debt Ratio||0.46|
|Gross Margin||28.67%||Operating Margin||10.04%||Net Profit Margin||3.29%||Dividend Payout Ratio||-36.74%|
|Cash From Financing Activities||-110.87 M||Cash From Investing Activities||-252.29 M||Cash From Operating Activities||410.09 M||Gross Profit||925.35 M|
|Net Profit||-110.62 M||Operating Profit||-64.16 M||Total Assets||18.37 B||Total Current Assets||4.3 B|
|Total Current Liabilities||2.68 B||Total Debt||8.5 B||Total Liabilities||13.4 B||Total Revenue||3.29 B|
|High 52 week||76.08||Low 52 week||43.42||Last close||59.69||Last change||-0.17%|
|RSI||56.53||Average true range||1.28||Beta||0.63||Volume||417.62 K|
|Simple moving average 20 days||1.52%||Simple moving average 50 days||9.35%||Simple moving average 200 days||6.41%|
|Performance Week||-0.68%||Performance Month||5.81%||Performance Quart||14.55%||Performance Half||6.34%|
|Performance Year||-16.52%||Performance Year-to-date||15.99%||Volatility daily||1.43%||Volatility weekly||3.2%|
|Volatility monthly||6.55%||Volatility yearly||22.71%||Relative Volume||157.6%||Average Volume||2.26 M|
|New High||New Low|
2019-08-22 16:24:15 | Andreas Halvorsen Keeps Buying Centene, DaVita
2019-08-22 06:30:00 | Davita Announces Final Results Of Self-Tender Offer
2019-08-21 09:12:46 | DaVita buys back $1.2 billion worth of stock from shareholders
2019-08-20 07:45:11 | Here's Why You Should Invest in DaVita DVA Stock For Now
2019-08-19 17:21:21 | Wall Street Rallies Monday
2019-08-19 09:35:01 | Is DaVita DVA a Profitable Stock for Value Investors Now?
2019-08-19 06:55:10 | 5 Price-to-Book Value Picks to Improve Portfolio Returns
2019-08-19 06:30:00 | DaVita Announces Preliminary Results Of Self-Tender Offer
2019-08-16 16:09:06 | Main Wall Street Indexes Extend Gains Friday
2019-08-16 08:53:12 | Outlook for Outpatient and Home Healthcare Industry Looks Bright
2019-08-16 07:16:58 | SSM Health partners with Denver firm to offer new primary care option
2019-08-13 09:30:01 | DVA or CHE: Which Is the Better Value Stock Right Now?
2019-08-13 09:26:01 | 5 Safe Picks Amid Yield Inversion and Geopolitical Concerns
2019-08-13 09:15:01 | Better Than Last Monday, but Still Down Over 1%
2019-08-12 11:46:00 | DaVita Announces New Senior Secured Credit Agreement
2019-08-08 10:20:02 | Why DaVita HealthCare DVA Might be Well Poised for a Surge
2019-08-07 06:50:10 | 5 Value Picks Boasting Strikingly Low EV/EBITDA Ratios
2019-08-06 09:20:01 | Relative Price Strength Make These 5 Stocks Worth a Look Now
2019-08-06 09:19:01 | 5 Stocks to Buy on a Possible Second Rate Cut in September
2019-08-05 10:25:02 | Stock Market News For Aug 5, 2019
2019-08-04 23:12:35 | Edited Transcript of DVA earnings conference call or presentation 1-Aug-19 9:00pm GMT
2019-08-02 10:22:02 | Stock Market News for Aug 02, 2019
2019-08-02 09:32:35 | DaVita sees growth slowdown ahead of federal changes to kidney care
2019-08-02 08:22:12 | DaVita DVA Earnings Beat, Revenues Miss Estimates in Q2
2019-08-02 03:24:23 | DaVita DVA Q2 2019 Earnings Call Transcript
2019-08-01 17:15:09 | DaVita HealthCare DVA Q2 Earnings Top Estimates
2019-08-01 16:01:00 | DaVita Inc. 2nd Quarter 2019 Results
2019-08-01 07:56:11 | 6 Promising Price-to-Book Value Stocks to Buy in August
2019-08-01 07:36:37 | Earnings Preview For DaVita
2019-07-31 09:05:01 | Can BD Medical Drive Becton, Dickinson's BDX Q3 Earnings?
2019-07-30 12:28:00 | Innovation in Home Care Delivery Improves the Quality of Life for More Kidney Patients
2019-07-30 09:15:01 | All Mixed Up to Start Fed Week
2019-07-30 09:14:32 | At US$59.66, Is It Time To Put DaVita Inc. NYSE:DVA On Your Watch List?
2019-07-30 08:56:12 | Cigna CI to Report Q2 Earnings: What's in the Offing?
2019-07-29 11:14:03 | Is a Beat in the Cards for Humana's HUM Earnings in Q2?
2019-07-29 10:04:02 | What's in the Cards for DaVita DVA This Earnings Season?
2019-07-29 09:25:35 | DaVita talks plans for home dialysis growth in wake of federal order
2019-07-26 13:49:41 | Reducing Blind Spots
2019-07-26 10:11:02 | Top Ranked Momentum Stocks to Buy for July 26th
2019-07-25 10:33:02 | DaVita HealthCare DVA Earnings Expected to Grow: Should You Buy?
2019-07-25 09:30:01 | DVA vs. CHE: Which Stock Is the Better Value Option?
2019-07-23 11:54:10 | US Stocks Climb Monday
2019-07-23 09:39:01 | Stock Market News For Jul 23, 2019
2019-07-23 08:48:12 | DaVita DVA Announces Preliminary Q2 Results, View Upbeat
2019-07-22 13:39:56 | DaVita News: DVA Stock Soars on Upbeat Guidance